These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1662 related articles for article (PubMed ID: 17593010)
1. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis. Duvvuri S; Janoria KG; Pal D; Mitra AK J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010 [TBL] [Abstract][Full Text] [Related]
2. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir. Duvvuri S; Janoria KG; Mitra AK J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919 [TBL] [Abstract][Full Text] [Related]
3. Effect of polymer blending on the release of ganciclovir from PLGA microspheres. Duvvuri S; Gaurav Janoria K; Mitra AK Pharm Res; 2006 Jan; 23(1):215-23. PubMed ID: 16320000 [TBL] [Abstract][Full Text] [Related]
4. Effect of lactide/glycolide ratio on the in vitro release of ganciclovir and its lipophilic prodrug (GCV-monobutyrate) from PLGA microspheres. Janoria KG; Mitra AK Int J Pharm; 2007 Jun; 338(1-2):133-41. PubMed ID: 17363204 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, physicochemical properties and ocular pharmacokinetics of thermosensitive in situ hydrogels for ganciclovir in cytomegalovirus retinitis treatment. Wang Q; Sun C; Xu B; Tu J; Shen Y Drug Deliv; 2018 Nov; 25(1):59-69. PubMed ID: 29228826 [TBL] [Abstract][Full Text] [Related]
6. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related]
7. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process. Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241 [TBL] [Abstract][Full Text] [Related]
8. Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery. Chowdhury DK; Mitra AK Pharm Dev Technol; 2000; 5(2):279-85. PubMed ID: 10810757 [TBL] [Abstract][Full Text] [Related]
9. Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis. Kunou N; Ogura Y; Yasukawa T; Kimura H; Miyamoto H; Honda Y; Ikada Y J Control Release; 2000 Aug; 68(2):263-71. PubMed ID: 10925134 [TBL] [Abstract][Full Text] [Related]
10. Biodegradable ibuprofen-loaded PLGA microspheres for intraarticular administration. Effect of Labrafil addition on release in vitro. Fernández-Carballido A; Herrero-Vanrell R; Molina-Martínez IT; Pastoriza P Int J Pharm; 2004 Jul; 279(1-2):33-41. PubMed ID: 15234792 [TBL] [Abstract][Full Text] [Related]
11. Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus. Veloso AA; Zhu Q; Herrero-Vanrell R; Refojo MF Invest Ophthalmol Vis Sci; 1997 Mar; 38(3):665-75. PubMed ID: 9071221 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir. Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable poly(D, L-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Su ZX; Shi YN; Teng LS; Li X; Wang LX; Meng QF; Teng LR; Li YX Pharm Dev Technol; 2011 Aug; 16(4):377-84. PubMed ID: 20370594 [TBL] [Abstract][Full Text] [Related]
14. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition. Kwon YM; Kim SW Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317 [TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying. Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422 [TBL] [Abstract][Full Text] [Related]
16. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. Sakurai E; Matsuda Y; Ozeki H; Kunou N; Nakajima K; Ogura Y Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2043-8. PubMed ID: 11481270 [TBL] [Abstract][Full Text] [Related]
17. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333 [TBL] [Abstract][Full Text] [Related]
18. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S; Faraj J; DeLuca P Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159 [TBL] [Abstract][Full Text] [Related]
19. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells. Kavas A; Keskin D; Altunbaş K; Tezcaner A Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363 [TBL] [Abstract][Full Text] [Related]
20. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres. Kim JH; Taluja A; Knutson K; Han Bae Y J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]